JPH0132236B2 - - Google Patents
Info
- Publication number
- JPH0132236B2 JPH0132236B2 JP62024594A JP2459487A JPH0132236B2 JP H0132236 B2 JPH0132236 B2 JP H0132236B2 JP 62024594 A JP62024594 A JP 62024594A JP 2459487 A JP2459487 A JP 2459487A JP H0132236 B2 JPH0132236 B2 JP H0132236B2
- Authority
- JP
- Japan
- Prior art keywords
- androstene
- chloroform
- dione
- methanol
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- 102000014654 Aromatase Human genes 0.000 description 10
- 108010078554 Aromatase Proteins 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- UKVVNEHFNYKGMX-KIVPVIKRSA-N (8r,9s,10r,13s,14r)-14-hydroxy-10,13-dimethyl-2,7,8,9,11,12,15,16-octahydro-1h-cyclopenta[a]phenanthrene-3,6,17-trione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3CC(=O)C2=C1 UKVVNEHFNYKGMX-KIVPVIKRSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960005471 androstenedione Drugs 0.000 description 3
- 150000001443 androstenes Chemical class 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000012156 elution solvent Substances 0.000 description 3
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000228417 Sarocladium strictum Species 0.000 description 2
- GOPYZMJAIPBUGX-UHFFFAOYSA-N [O-2].[O-2].[Mn+4] Chemical class [O-2].[O-2].[Mn+4] GOPYZMJAIPBUGX-UHFFFAOYSA-N 0.000 description 2
- 150000001440 androstane derivatives Chemical class 0.000 description 2
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- UDHAKZRCGHAPAZ-NFBMXZEVSA-N (6r,8r,9s,10r,13s,14r)-6,14-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3C[C@@H](O)C2=C1 UDHAKZRCGHAPAZ-NFBMXZEVSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024594A JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
| AT88901462T ATE78825T1 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| DE8888901462T DE3873200T2 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| EP88901462A EP0300062B1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| PCT/JP1988/000114 WO1988005781A1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| US07/279,596 US4975368A (en) | 1987-02-06 | 1988-09-26 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
| US07/555,691 US5079377A (en) | 1987-02-06 | 1990-07-23 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024594A JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63192794A JPS63192794A (ja) | 1988-08-10 |
| JPH0132236B2 true JPH0132236B2 (cs) | 1989-06-29 |
Family
ID=12142482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62024594A Granted JPS63192794A (ja) | 1987-02-06 | 1987-02-06 | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63192794A (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0643439B2 (ja) * | 1989-02-07 | 1994-06-08 | 雪印乳業株式会社 | 光による６β，１４α‐ジヒドロキシ‐４‐アンドロステン‐３，１７‐ジオンの６β位水酸基の酸化方法 |
| JP2602456B2 (ja) * | 1990-04-12 | 1997-04-23 | 雪印乳業株式会社 | 子宮内膜症治療剤 |
-
1987
- 1987-02-06 JP JP62024594A patent/JPS63192794A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63192794A (ja) | 1988-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Laskin et al. | Transformations of Eburicoic Acid. V. 1 Cleavage of Ring A by the Fungus Glomerella fusarioides | |
| FUKUDA et al. | A method to screen anticholesterol substances produced by microbes and a new cholesterol oxidase produced by Streptomyces violascens | |
| WO1991018003A1 (en) | Antitumor be-13793c derivative | |
| EP0300062B1 (en) | Novel androst-4-ene-3,17-dione derivatives and process for their preparation | |
| Medici et al. | 7α-OH epimerisation of bile acids via oxido-reduction with Xanthomonas maltophilia | |
| JPH0132236B2 (cs) | ||
| CN116284199A (zh) | 积雪草酸微生物转化衍生物及其制备方法与应用 | |
| JP2689144B2 (ja) | ７〆，１１〆−ジヒドロキシーアンドロストー１，４−ジエン−３，１７−ジオン | |
| JPH0150717B2 (cs) | ||
| JP2622712B2 (ja) | ７α，１４α−ジヒドロキシ−アンドロスト−１，４−ジエン−３，１７−ジオン | |
| JPH0369357B2 (cs) | ||
| JPH0150716B2 (cs) | ||
| JP2622700B2 (ja) | １５β‐ヒドロキシ‐１９‐ノル‐テストステロン | |
| JP2001523259A (ja) | ４−アザ−ステロイド類 | |
| CN101362788B (zh) | 6α-溴-雄甾-4-烯-3,17-二酮的合成方法 | |
| Breiter et al. | Microbial hydroxylation of androsta-1, 4-diene-3, 17-dione | |
| JPH06225793A (ja) | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオンの新規製造法 | |
| JPH01229000A (ja) | ２（３―ハイドロキシ―１，３，５（１０）―エストリエン―１７―イル）プロピオン酸の製造法 | |
| DE1593327C (de) | Verfahren zur Herstellung von Delta hoch 1,4 -Androstadien-3,17-dion, Delta hoch 1,4 -Androstadien-3,11,17-trion bzw. Delta hoch 1,4 -Androstadien-1 lalpha-ol-3,17-dion | |
| JPS63192797A (ja) | ６β，１４α−ジヒドロキシ−△↑４−アンドロステン−３，１７−ジオン誘導体 | |
| RU2077590C1 (ru) | Способ получения 9-альфа-оксиандрост-4-ен-3,17-диона | |
| JPH0662576B2 (ja) | マイコトリエニン系化合物 | |
| JPS63192799A (ja) | ７β，１５β，１７α−トリヒドロキシ−４−プレグネン−３，２０−ジオン | |
| Rasras et al. | Synthesis and Antimicrobial Studies of Some New Cholic Acid Derivatives | |
| WO1994018190A1 (en) | Depsidone compound |